Journal of the American Chemical Society · 2011 · 122 citations · 57 references
Life SciencesBiochemistryMolecular BiologyDrug DiscoveryEnzymologyPost-translational ModificationFatty Acid BiosynthesisFatty Acid SynthesisLipid BiosynthesisMicrobial Natural Product BiosynthesisNonribosomal Peptide BiosynthesisAmino AcidsBiosynthetic Gene Cluster AnalysisCytochrome P450 MonooxygenasesFatty Acid Precursor BiosynthesisNon-ribosomal Peptide BiosynthesisPlatelet-derived Growth Factor InhibitionPlatelet-derived Growth Factor Receptor SignalingPlatelet-derived Growth Factor Receptors
The cyclic depsipeptide skyllamycin A is a potent inhibitor of the platelet-derived growth factor (PDGF) signaling pathway by inhibiting binding of homodimeric PDGF BB to the PDGF β-receptor. Its structure contains a cinnamoyl side chain and shows a high amount of β-hydroxylated amino acids as well as an unusual α-hydroxyglycine moiety as a rare structural modification. The skyllamycin biosynthetic gene cluster was cloned and sequenced from Streptomyces sp. Acta 2897. Its analysis revealed the presence of open reading frames encoding proteins for fatty acid precursor biosynthesis, non-ribosomal peptide synthetases, regulators, and transporters along with other modifying enzymes. Specific in-frame mutagenesis of these tailoring enzymes resulted in the production of novel skyllamycin derivatives revealing that β-hydroxy groups in skyllamycin A are introduced by a promiscuous cytochrome P450 monooxygenase, whereas a two-component flavin-dependent monooxygenase is involved in α-hydroxylation.
57
Molecular cloning: A laboratory manual
Prescott L. Deininger · Analytical Biochemistry · 1990 · 86.2K citations
The Pfam protein families database
ROBERT FINN, Jaina Mistry, John Tate et al. · Nucleic Acids Research · 2009 · 2.7K citations · Full text
Bertolt Gust, Gregory L. Challis, Kay Fowler et al. · Proceedings of the National Academy of Sciences · 2003 · 1.4K citations